Downregulation of DNA-PKcs levels or catalytic activity may contribute to the pathogenesis of neurodegenerative diseases such as AD (Kanungo, 2016; Lin et al., 2020) and motor neuron disorders ALS and SMA as discussed below. The gene discussed is SMN1; the disease is Alzheimer disease.